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Role of atrial natriuretic factor, cyclic GMP and the 
renin-aldosterone system in acute volume regulation 
of healthy human subjects 
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Received 21 October 1987 and in revised form 11 March 1988 
Abstract. The role of the atrial natriuretic factor 
(ANF), its second messenger cyclic guanosine mono-
phosphate (cGMP), and the counteracting renin-
aldosterone system in acute volume regulation was 
investigated in 25 healthy human subjects. Central 
volume stimulation by 1-h head-out water immersion 
(WI) into a thermoneutral water-bath increased 
plasma levels of A N F (mean + SEM) from 6-0 ± 0-6 to 
13-6 + 2*6 fmol m l - 1 . This was paralleled by a rise of 
plasma cGMP levels from 1-9 + 0-2 to 2-8 + 0-4 pmol 
ml 1, and an increase of urinary c G M P excretion from 
340 + 64 to 692+ 103 pmol min - 1 . Water immersion 
reduced plasma aldosterone concentration (PAC) 
from 130+1-7 to 6-5 + 0-8 ng 100 ml" 1 and plasma 
renin activity (PRA) from 5-3 + 0-9 to 2-4 + 0-3 ng AI 
ml" 1 h _ l . Volume stimulation markedly increased 
diuresis and natriuresis. Whereas the plasma cGMP 
increase correlated with plasma A N F stimulation, 
neither A N F nor PR A or PAC correlated with basal or 
stimulated renal parameters. Water immersion-
induced changes in natriuresis and urinary cGMP 
excretion were correlated. These data suggest a role of 
A N F and cGMP in acute volume regulation of healthy 
human subjects. 
Keywords. Atrial natriuretic factor, volume regulation, 
water immersion, cyclic GMP, renin-aldosterone sys-
tem. 
Introduction 
The atria have long been attributed an essential role in 
the regulation of extracellular volume by influencing 
Abbreviations: A N F , atrial natriuretic factor; cGMP, cyclic 
guanosine monophosphate; PRA, plasma renin activity; PAC, 
plasma aldosterone concentration; cGMPV, urinaiy excretion of 
cGMP; UV, urinary flow rate; UNaV, urinary sodium excretion; 
UKV, urinary potassium excretion; CCr, creatinine clearance; WI, 
head-out water immersion. 
Correspondence: Dr Alexander L. Gerbes, MD, Medizinische 
Klinik II, Klinikum Großhadern, University of Munich, Marchioni-
nistr.15, D-8000 Munich 70, F R G . 
renal sodium and water handling [1]. However, the 
hormonal mediators by which the heart modifies renal 
function have not been satisfactorily defined. With the 
discovery of the atrial natriuretic factor (ANF), a new 
agent in the concert of volume regulating systems has 
to be considered in health and disease states [2, 3]. The 
peptide is stored in granules of atrial myocytes and 
released upon atrial distension [4, 5]. There is evidence 
for a physiological role of A N F [6], which counteracts 
sodium-retaining principles, such as the renin-aldo-
sterone system [7]. 
Head-out water immersion (WI) increases central 
venous and atrial volume by shifting blood from 
peripheral vessels to the intrathoracic venous bed— 
thus obviating the necessity of infusing volume 
expanders that might alter plasma composition [8]. In 
a preliminary study we had been able to demonstrate 
that WI stimulates ANF release in man [9] and thus 
seems to be a useful tool to study the physiological role 
of A N F in acute volume regulation. Several observa-
tions support the contention that cellular actions of 
A N F are mediated by cyclic guanosine monophos-
phate (cGMP) [10]. Administration of pharmacologi-
cal doses of A N F [11], as well as volume stimulation in 
the animal [12], have been shown to increase plasma 
concentration and urinary excretion of cGMP. In the 
present study, the effects of an endogenous A N F 
release by volume stimulation on cGMP were exam-
ined. 
The aim of the present study was to investigate the 
role of A N F and cGMP, as well as its interaction with 
the renin-aldosterone system, in the renal response to 
acute volume stimulation by water immersion. 
Patients and methods 
Twenty-five subjects, 16 men and nine women, aged 
19-65 years, were investigated after their informed 
consent had been obtained. The protocol was 
approved by the Ethical Committee of the Faculty of 
Medicine, University of Munich. The subjects showed 
no evidence of cardiovascular, renal, pulmonary, 
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endocrine or urinary tract diseases. They took no 
medications, were on a regular diet, containing 
approximately 150 meq sodium d a y - 1 , and were 
prohibited alcohol, tobacco, tea and coffee the day 
before and during the experiment. In the morning after 
complete emptying of the bladder, an intravenous 
cathether was placed into a forearm vein, subjects were 
given 400 ml of water orally and they assumed a seated 
position next to the immersion tank. After 1 h, the 
subjects were immersed to their neck, maintaining the 
same seated position, into thermoneutral water 
(34-5±0-2°C) for 1 h. This was followed by a 1-h 
period of sitting outside the tank. Throughout the 
investigation, 200 ml water h _ 1 were given orally to 
ensure adequate urine flow. All the urine voided by 
spontaneous emptying of the bladder, as well as 
plasma samples, were collected before (baseline), after 
1 h WI (immersion) and 1 h subsequent to the end of 
WI (recovery). 
Urine was analysed for sodium and potassium 
(flame photometry) and creatinine (Jaffe reaction). 
Plasma renin activity (PRA) was measured by 
radioimmunoassay after 1-h incubation at 37°C, pH 
5-9, as described previously [13]. Plasma aldosterone 
concentration (PAC) was determined by use of a 
commercial solid-phase radioimmunoassay (Diagnos-
tic products, U.S.A.). Atrial natriuretic factor was 
measured in XAD-extracted plasma samples by 
radioimmunoassay, as described earlier [14]. Briefly, 
the antibody is mid-molecule- and C-terminal-dir-
ected. Cross-reactivity was 70% to rat A N F 99-126, 
13% to atriopeptin III, 0 0 3 % to atriopeptins I or II. It 
did not cross-react with a wide variety of peptides and 
proteins, including its immunization conjugate (bovine 
thyreoglobulin). The final titre was 1:120 000 and the 
assay sensitivity was 0-5 fmol per assay tube. The 50%-
binding intercept of the standard curve was 10 fmol. 
One-millilitre plasma aliquots were extracted by 
adsorption to pre-rinsed Amberlite XAD-2 adsorbent 
resin (particle size 0-3-1-0 mm, Serva, Heidelberg, 
FRG). Recovery of synthetic human A N F 99-126 was 
approximately 67%. Intra-assay variation was < 10% 
(« = 8), inter-assay variation was < 15% (« = 6). In 18 
subjects baseline, immersion and recovery plasma 
samples, and in 15 subjects urine samples, were 
analysed for cGMP by radioimmunoassay according 
to a method described previously [11]. 
Clearance of creatinine (CCr) was calculated by the 
standard formula. 
Data are given as means and standard error of the 
mean. Following a Kolmogorov-Smirnoff test for 
random distribution, statistical evaluation was done 
by Wilcoxon's test or by Student's paired /-tests; a 
probability value of P = 0 0 5 or less was considered 
significant. The Pearson correlation coefficient was 
determined by the usual linear least-squares method. 
Results 
ANF and cGMP 
As shown in Fig. 1, WI significantly increased A N F 
plasma concentrations from 6-0±0-6 to 13-6±2-6 
fmol ml ~1. Atrial natriuretic factor increased in all but 
three subjects; mean stimulation was by 117 + 29%. In 
the recovery period, ANF decreased to baseline levels. 
The stimulation of A N F was paralleled by an increase 
of plasma cGMP concentration from 1-9 + 0-2 to 
2-8 + 0-4 pmol ml - 1 , returning to 2-0 + 0-2 pmol m l - 1 
in the recovery period. Likewise, urinary cGMP 
excretion rose from 340 + 64 (baseline value) to 
9 0 0 -~ 
6 0 0 
3 0 0 
CL 
o 
Boso Immersion Recovery 
Figure 1. Plasma concentrations of atrial natriuretic factor ( ^ : 
ANF) cyclic guanosine monophosphate ( • : cGMP) and renal 
excretion of c G M P ( • ) before, during and subsequent to head-out 
water immersion of 25 healthy human subjects. * P < 0 0 5 , 
* * P < 0 - 0 1 , significantly different from baseline level. 
Table 1. Renal response to acute volume stimulation by water immersion in 
25 healthy human subjects 
Baseline Immersion Recovery 
1-4 + 0-2 5-0 + 0-6*** 2-8 + 0-4* 
0 16 + 0 0 2 0-30 + 0-03*** 0 18 + 0 0 3 
Urinary volume 
(ml min~ ' ) 
Urinary sodium excretion 
(mmol min~ ' ) 
Urinary potassium excretion 0 0 7 + 0 0 1 0 1 4 + 002*** 0 0 7 + 001 
(mmol min - ' ) 
Creatinine clearance 
(ml m i n - ' ) 153±26 200 + 32 117±15 
* P < 0 0 5 , ***/>< 0-001, significantly different from baseline level. 
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ANF immersion / basel ine Figure 2. Correlation of immersion-induced stimulation of A N F 
plasma concentrations with plasma concentrations of c G M P 
(immersion/baseline ratios); r=0-68 , P < 0 0 0 2 . 
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Figure 4. Correlation of immersion-induced stimulation of natriure-
sis (UNaV) with urinary c G M P excretion (immersion/baseline 
ratios); r = 0-61, P<002. 
692 + 103 pmol min" ' , and then returned to 437 + 79 
pmol min - 1 . 
While neither basal nor stimulated values of A N F 
and cGMP correlated significantly, changes of cGMP 
were closely correlated with changes of A N F (r = 0-68, 
P < 0-002; Fig. 2). 
6-5 + 0-8 ng 100 m l " \ with recovery values of 8-1 ± 1 -4 
ng 100 m l - 1 . Basal PAC and PRA values were 
significantly correlated (r = 0-56, P<0*01) as were the 
WI-induced changes of both hormones (r = 0-65, 
/>< 0-002). 
Renin-aldosterone 
The effects of WI on plasma renin activity and plasma 
aldosterone concentration are shown in Fig. 3. Plasma 
renin activity decreased from 5-3 + 0-9 (baseline) to 
2-4 + 0*3 ng m l - 1 h"1 , returning to 3-7 + 0-5 ng ml" 1 
h _ l . Similarly, PAC was suppressed from 13-0+ 1-7 to 
Renal response 
Table 1 displays the effects of WI on renal excretion. 
All but five subjects responded to WI with an increase 
in sodium excretion. Mean values of sodium excretion 
were increased two-fold during immersion. Highly 
significant enhancements by volume stimulation were 
also observed for urinary flow rate and for potassium 
excretion. Increases of creatinine clearance ( P > 0 T ) 













Figure 3. Plasma aldosterone concentration ( • : PAC) and plasma 
renin activity ( ^ : PRA) before, during and subsequent to immer-
sion. * * / > < 0 0 1 , ***/><0-001, significantly different from baseline 
level. 
Relationship of ANF to renin-aldosterone and renal 
response 
Water immersion induced stimulation of A N F as well 
as suppression of PRA and PAC. However, no 
relationship between these hormonal changes could be 
found. Tendencies for negative correlations between 
basal (r=— 0-37) as well as stimulated (r=— 0-30) 
values of A N F and corresponding values of PAC did 
not reach significance ( P > 0 T ) . 
Neither basal nor stimulated natriuresis or diuresis 
correlated with A N F , PRA or PAC values. Changes of 
urinary cGMP excretion correlated with the increase 
of natriuresis (r = 0-61, P<0-02) (Fig. 4). 
Discussion 
The present study demonstrates that acute central 
volume stimulation by water immersion induces a 
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highly significant increase of A N F plasma levels in 
healthy human subjects. However, large variations of 
response were observed, with three of 25 subjects 
exhibiting no stimulation of plasma ANF, despite a 
suppression of PRA as an indicator of central volume 
stimulation. In these subjects mean urinary sodium 
excretion increased less than in the subjects with A N F 
increase (002 vs. 0 1 6 m m o l min - 1 ) , possibly suggest-
ing a physiological importance of A N F in WI-induced 
natriuresis. 
Cyclic G M P is being considered a second messenger 
of cellular A N F action [10]. In this study we investi-
gated cGMP upon endogenous ANF release by 
volume stimulation. Basal plasma levels of cGMP were 
not correlated with basal A N F levels. This finding is in 
accordance with unpublished observations in other 
subjects (R. Gerzer et a/.), and might be due to 
stimulation of guanylate cyclase by substances other 
than A N F [15-17]. However, as A N F is the only 
hormonal stimulator of particulate guanylate cyclase 
described so far [10], corresponding changes of c G M P 
with A N F stimulation might be expected. Indeed, 
immersion-induced changes of plasma cGMP levels 
were closely correlated with changes of plasma A N F 
levels. These findings demonstrate that in man endo-
genous stimulation of A N F in the physiological range 
is accompanied by increases of plasma cGMP, and 
support the contention that cGMP acts as a second 
messenger of ANF. 
Water immersion prompted significant decreases of 
PRA and PAC in all but two subjects. These two 
persons, however, exhibited stimulated A N F plasma 
levels as well as natriuresis and diuresis, indicating that 
suppression of the renin-aldosterone system cannot 
fully account for the renal response to WI. Basal 
plasma levels of PRA and PAC, as well as changes by 
volume stimulation, were found to correlate signifi-
cantly. Administration of A N F in pharmacological 
doses can reduce renin and aldosterone secretion [18, 
19] and decrease their plasma levels [20]. Therefore, in 
view of WI-induced changes of ANF reciprocal to 
changes of PRA and PAC, the significance of correla-
tion of these hormonal changes by WI was investi-
gated. However, only trends for negative correlation of 
basal as well as stimulated values of A N F with the 
corresponding PAC values were observed. Therefore 
these data do not provide strong evidence that a 
physiological increase of A N F suppresses PRA or 
PAC, although this possibility cannot be excluded. 
Water immersion caused a significant increase of 
natriuresis and diuresis, consistent with the renal 
response observed by others in this standard model of 
volume stimulation [21]. However, in five of the 25 
subjects, at comparable basal sodium excretion, no 
increase of natriuresis was induced. Thus, variations of 
basal natriuresis, possibly reflecting differences in 
dietary sodium intake, do not seem to have a major 
influence on the WI-induced renal response. Observa-
tions in these five non-responders suggested a role for 
the A N F system in mediating the renal reaction to WI: 
mean increase of ANF plasma levels in non-res-
ponders was only 4-6 ± 2-0 fmol ml" \ compared with a 
8-4 + 2-8 fmol ml - 1 increase in the responding subjects. 
In three of the non-responders, urinary c G M P excre-
tion was determined. As opposed to a mean increase of 
cGMPV by 9 1 % , non-responders showed no stimula-
tion of cGMPV. Furthermore, changes of cGMPV 
varied significantly with changes of natriuresis by 
immersion. This may support the hypothesis that 
urinary GMP, and more so its changes, reflect renal 
action of ANF [21,22]. 
Immersion induced an increase of potassium excre-
tion. This phenomenon has been attributed to an 
increased distal delivery of filtrate and to an increase of 
urine flow by WI [23]. A kaliuretic effect of ANF, 
observed after high dose bolus injection in rats [24], 
might possibly have contributed to the increase of 
renal potassium excretion. However, several reports 
indicate that A N F administration in normal man does 
not significantly affect kaliuresis [20, 25]. In our study, 
potassium excretion was not significantly correlated 
with ANF plasma levels. The aforementioned studies 
in man, as well as this observation, do not support the 
notion of an A N F effect on kaliuresis. Furthermore, 
diuresis 1 h after the end of WI was significantly higher 
than before WI, while A N F concentrations had 
returned to basal levels. Thus, a role of other mediators 
of volume regulation, apart from A N F , must be 
recognized. 
From the present data it can be concluded that ANF 
is released upon acute volume stimulation in healthy 
subjects, inducing increases of both plasma cGMP 
levels and urinary cGMP excretion. 
Whereas immersion suppresses the sodium-retain-
ing renin-aldosterone system, together with the stimu-
lation of ANF, no correlation of any of these hor-
mones with the renal response was observed. Thus, 
volume regulation may be influenced by complex 
interaction of the ANF system with other humoral 
factors, such as the renin-aldosterone system. Investi-
gation of these hormonal interactions in disease states 
with impairment of volume regulation might shed 
further light on the pathophysiological importance of 
ANF. 
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